MML Investors Services
AZN icon

MML Investors Services’s AstraZeneca AZN Stock Holding History

MML Investors Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5M Buy
171,254
+31,137
+22% +$5.86M 0.07% 298
2026
Q1 		$27.6M Sell
140,117
-12,701
-8% -$2.45M 0.08% 260
2025
Q4 		$28.1M Buy
152,818
+16,169
+12% +$2.84M 0.07% 275
2025
Q3 		$21M Buy
136,649
+8,515
+7% +$1.29M 0.06% 328
2025
Q2 		$17.9M Sell
128,134
-5,283
-4% -$740K 0.05% 358
2025
Q1 		$19.6M Buy
133,417
+5,112
+4% +$740K 0.07% 303
2024
Q4 		$16.8M Buy
128,305
+502
+0.4% +$70.3K 0.06% 322
2024
Q3 		$19.9M Buy
127,803
+3,967
+3% +$640K 0.07% 267
2024
Q2 		$19.3M Sell
123,836
-877
-0.7% -$132K 0.08% 253
2024
Q1 		$16.9M Buy
124,713
+3,141
+3% +$416K 0.07% 284
2023
Q4 		$16.4M Buy
121,572
+25,675
+27% +$3.34M 0.08% 258
2023
Q3 		$13M Buy
95,897
+8,354
+10% +$1.14M 0.07% 271
2023
Q2 		$12.5M Buy
+87,543
New +$12.9M 0.07% 278
2023
Q1 		– Sell
-68,583
Closed -$9.3M – 2077
2022
Q4 		$9.3M Buy
68,583
+2,391
+4% +$300K 0.06% 318
2022
Q3 		$7.26M Buy
66,192
+11,980
+22% +$1.52M 0.06% 332
2022
Q2 		$7.16M Buy
54,212
+7,081
+15% +$929K 0.05% 318
2022
Q1 		$6.25M Buy
47,131
+4,119
+10% +$494K 0.04% 376
2021
Q4 		$5.01M Buy
43,012
+1,030
+2% +$121K 0.04% 441
2021
Q3 		$5.04M Buy
41,982
+8,067
+24% +$939K 0.04% 417
2021
Q2 		$4.06M Buy
33,915
+5,674
+20% +$623K 0.03% 456
2021
Q1 		$2.81M Buy
28,241
+2,587
+10% +$260K 0.03% 536
2020
Q4 		$2.56M Buy
25,654
+2,983
+13% +$316K 0.03% 493
2020
Q3 		$2.48M Buy
22,671
+325
+1% +$36.1K 0.03% 448
2020
Q2 		$2.36M Buy
22,346
+3,402
+18% +$351K 0.03% 441
2020
Q1 		$1.69M Buy
18,944
+5,421
+40% +$510K 0.03% 465
2019
Q4 		$1.35M Buy
13,523
+222
+2% +$20.9K 0.02% 607
2019
Q3 		$1.19M Buy
13,301
+548
+4% +$47.5K 0.02% 610
2019
Q2 		$1.05M Buy
12,753
+524
+4% +$41.1K 0.02% 699
2019
Q1 		$989K Sell
12,229
-13,613
-53% -$1.07M 0.02% 703
2018
Q4 		$1.96M Sell
25,842
-3,278
-11% -$256K 0.04% 420
2018
Q3 		$2.3M Sell
29,120
-3,014
-9% -$228K 0.04% 399
2018
Q2 		$2.26M Sell
32,134
-2,318
-7% -$167K 0.05% 326
2018
Q1 		$2.41M Sell
34,452
-5,695
-14% -$394K 0.05% 309
2017
Q4 		$2.79M Buy
40,147
+5,000
+14% +$337K 0.05% 280
2017
Q3 		$2.38M Buy
35,147
+8,436
+32% +$533K 0.05% 295
2017
Q2 		$1.82M Buy
26,711
+2,195
+9% +$143K 0.04% 352
2017
Q1 		$1.53M Buy
+24,516
New +$1.43M 0.03% 194

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

MML Investors Services's AZN Position: Q2 2026 in Review

MML Investors Services increased its AstraZeneca (AZN) stake by 22% in Q2 2026, buying an estimated $5.86M and bringing the position to 171,254 shares worth $32.5M. The position accounts for 0.07% of the portfolio, ranked #298.

MML Investors Services first reported a position in AZN in Q1 2017 and has held it in 37 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • MML Investors Services held 171,254 shares of AstraZeneca worth $32.5M as of Q2 2026.
  • MML Investors Services bought 31,137 AstraZeneca shares in Q2 2026, an estimated $5.86M.
  • AstraZeneca made up 0.07% of MML Investors Services's portfolio in Q2 2026, its #298 holding.
  • MML Investors Services first reported a position in AstraZeneca in Q1 2017 and has held it in 37 quarters since.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.